Bone metastatic prostate cancer cells secrete factors that promote osteoblast differentiation, including bone morphogenic proteins (BMPs), TGF-beta, IGF-1, platelet-derived growth factor, endothelin-1, and VEGF [8,93,116,117]. Here, IGF1 is linked to prostate carcinoma.